These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24581967)

  • 1. Relative ADC measurement for liver fibrosis diagnosis in chronic hepatitis B using spleen/renal cortex as the reference organs at 3 T.
    Hong Y; Shi Y; Liao W; Klahr NJ; Xia F; Xu C; Li Y; Guo Q
    Clin Radiol; 2014 Jun; 69(6):581-8. PubMed ID: 24581967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis.
    Sandrasegaran K; Akisik FM; Lin C; Tahir B; Rajan J; Saxena R; Aisen AM
    AJR Am J Roentgenol; 2009 Dec; 193(6):1556-60. PubMed ID: 19933647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of liver and spleen ADC measurements in the diagnosis and follow up of hepatic fibrosis in chronic liver disease.
    Tokgöz Ö; Unal I; Turgut GG; Yildiz S
    Acta Clin Belg; 2014 Dec; 69(6):426-32. PubMed ID: 25103596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of liver fibrosis and cirrhosis with diffusion-weighted imaging: value of normalized apparent diffusion coefficient using the spleen as reference organ.
    Do RK; Chandarana H; Felker E; Hajdu CH; Babb JS; Kim D; Taouli B
    AJR Am J Roentgenol; 2010 Sep; 195(3):671-6. PubMed ID: 20729445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of DWI to assess spleen and liver quantitative ADC changes in the detection of liver fibrosis stages in chronic viral hepatitis.
    Cece H; Ercan A; Yıldız S; Karakas E; Karakas O; Boyacı FN; Aydogan T; Karakas EY; Cullu N; Ulas T
    Eur J Radiol; 2013 Aug; 82(8):e307-12. PubMed ID: 23518145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study on clinical and pathological changes of liver fibrosis with diffusion-weighted imaging].
    Zhou ML; Yan FH; Xu PJ; Chen CZ; Shen JZ; Li RC; Ji Y; Shi JY
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(25):1757-61. PubMed ID: 19862980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the mean and entropy of apparent diffusion coefficient values in chronic hepatitis C: correlation with pathologic fibrosis stage and inflammatory activity grade.
    Fujimoto K; Tonan T; Azuma S; Kage M; Nakashima O; Johkoh T; Hayabuchi N; Okuda K; Kawaguchi T; Sata M; Qayyum A
    Radiology; 2011 Mar; 258(3):739-48. PubMed ID: 21248235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative apparent diffusion coefficient: determination of reference site and validation of benefit for detecting metastatic lymph nodes in uterine cervical cancer.
    Park SO; Kim JK; Kim KA; Park BW; Kim N; Cho G; Choi HJ; Cho KS
    J Magn Reson Imaging; 2009 Feb; 29(2):383-90. PubMed ID: 19161191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic hepatitis: role of diffusion-weighted imaging and diffusion tensor imaging for the diagnosis of liver fibrosis and inflammation.
    Taouli B; Chouli M; Martin AJ; Qayyum A; Coakley FV; Vilgrain V
    J Magn Reson Imaging; 2008 Jul; 28(1):89-95. PubMed ID: 18581382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience.
    Taouli B; Tolia AJ; Losada M; Babb JS; Chan ES; Bannan MA; Tobias H
    AJR Am J Roentgenol; 2007 Oct; 189(4):799-806. PubMed ID: 17885048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion kurtosis imaging with the breath-hold technique for staging hepatic fibrosis: A preliminary study.
    Yoshimaru D; Miyati T; Suzuki Y; Hamada Y; Mogi N; Funaki A; Tabata A; Masunaga A; Shimada M; Tobari M; Nishino T
    Magn Reson Imaging; 2018 Apr; 47():33-38. PubMed ID: 29158186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C.
    Lewin M; Poujol-Robert A; Boëlle PY; Wendum D; Lasnier E; Viallon M; Guéchot J; Hoeffel C; Arrivé L; Tubiana JM; Poupon R
    Hepatology; 2007 Sep; 46(3):658-65. PubMed ID: 17663420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-Weighted Imaging for Differentiation of Biliary Atresia and Grading of Hepatic Fibrosis in Infants with Cholestasis.
    Kim J; Shin HJ; Yoon H; Han SJ; Koh H; Kim MJ; Lee MJ
    Korean J Radiol; 2021 Feb; 22(2):253-262. PubMed ID: 32901459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Liver Fibrosis with Diffusion-Weighted Magnetic Resonance Imaging Using Different b-values in Chronic Viral Hepatitis.
    Kocakoc E; Bakan AA; Poyrazoglu OK; Dagli AF; Gul Y; Cicekci M; Bahcecioglu IH
    Med Princ Pract; 2015; 24(6):522-6. PubMed ID: 26183515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted magnetic resonance imaging for the assessment of liver fibrosis in chronic viral hepatitis.
    Charatcharoenwitthaya P; Sukonrut K; Korpraphong P; Pongpaibul A; Saiviroonporn P
    PLoS One; 2021; 16(3):e0248024. PubMed ID: 33662022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis.
    Koinuma M; Ohashi I; Hanafusa K; Shibuya H
    J Magn Reson Imaging; 2005 Jul; 22(1):80-5. PubMed ID: 15971188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial study of biexponential model of intravoxel incoherent motion magnetic resonance imaging in evaluation of the liver fibrosis.
    Chen C; Wang B; Shi D; Fu F; Zhang J; Wen Z; Zhu S; Xu J; Lin Q; Li J; Dou S
    Chin Med J (Engl); 2014; 127(17):3082-7. PubMed ID: 25189949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus.
    Besheer T; Elalfy H; Abd El-Maksoud M; Abd El-Razek A; Taman S; Zalata K; Elkashef W; Zaghloul H; Elshahawy H; Raafat D; Elemshaty W; Elsayed E; El-Gilany AH; El-Bendary M
    World J Gastroenterol; 2019 Mar; 25(11):1366-1377. PubMed ID: 30918429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing liver fibrosis: comparison of arterial enhancement fraction and diffusion-weighted imaging.
    Bonekamp D; Bonekamp S; Ou HY; Torbenson MS; Corona-Villalobos CP; Mezey E; Kamel IR
    J Magn Reson Imaging; 2014 Nov; 40(5):1137-46. PubMed ID: 24989329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted MRI in evaluating liver fibrosis: a feasibility study in cirrhotic patients.
    Girometti R; Furlan A; Bazzocchi M; Soldano F; Isola M; Toniutto P; Bitetto D; Zuiani C
    Radiol Med; 2007 Apr; 112(3):394-408. PubMed ID: 17440695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.